Adhere to Ethical Guidelines: Maintain the highest ethical standards in all research, particularly when exploring investigational compounds and combinations
Cost planning across the dose schedule The total cost of a retatrutide protocol varies significantly depending on which phase of the dose schedule you are in
Eli Lilly and Company, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), has announced positive topline results from a phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes
Not every patient is a suitable candidate
Common adverse effects associated with probiotic use are typically mild and gastrointestinal in nature: Bloating and gas, especially during the first few days of use Abdominal discomfort or cramping Changes in bowel habits (diarrhea or constipation) Nausea (less common) These symptoms usually resolve within one to two weeks as the gut microbiome adjusts
